Lipopolysaccharide (LPS) from E. coli O55:B5 is a potent immunostimulant that activates immune responses via TLR4. It is widely used to model inflammatory diseases such as arthritis, COPD, and ARDS in both in vitro cell studies and in vivo animal experiments.
